SM-102 is an ionizable synthetic amino lipid that binds to other lipids to form nanoparticles (LNPs). SM-102 has the potential to develop lipid nanoparticles for the delivery of mRNA-based vaccines. These are used to deliver mRNA-based vaccines, specifically SM-102 is part of Moderna’s COVID-19 vaccine drug delivery system.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.